Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasone
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two smaller relevant studies have been conducted that may help to fill this gap temporarily.”
From Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis (2019) · cites this paper as Heiser et al. [79]
In the citing paper
“They report that immune cells from depressed patients that were resistant to the anti-proliferative effects of glucocorticoids in vitro produced more TNF-α in response to a mitogen than controls.”
From Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis (2019) · cites this paper as Heiser et al. [79]
In the citing paper
“Inclusion of medication-free patients may be an important aspect to consider in the design of these studies also as levels of both cortisol and cytokines are modulated by antidepressant treatment (13, 79, 80).”
From Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis (2019) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365 · cited 1×
“On the other side, especially TNF-α has been linked to the depressive psychopathology (Lanquillon et al., 2000; Reichenberg et al., 2001).”
BackgroundCytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 6×
“Moreover, cytokines have been implicated in alterations in noradrenaline and serotonin turnover in brain regions involved in MDD and a lowered activity of presynaptic 5- HT neurons and an altered 5-HT uptake (for review see Schiepers et al., 2005).”
BackgroundInfluentialRaison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 4×
“…pituitary adrenocortical(HPA) axis in MDD and showed an altered feed-back regulation, probably indicative of a steroid resistance syndrome (Pariante and Miller, 2001; DeRijk and Sternberg, 1997), related to a putative dysfunction of corticosteroid (CS) receptors (Modell et al., 1997;…”
BackgroundInfluentialCytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Self-citationLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 6×
“…factors affected in MDD but also as important s reserved. variables contributing to the course and therapy response of the disorder (Weizman et al., 1994; Sluzewska et al., 1995; Frommberger et al., 1997; Maes et al., 1997; Licinio and Wong, 1999; Lanquillon et al., 2000; Anisman and Merali, 2003).”
BackgroundInfluentialFrommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362 · cited 2×
“variables contributing to the course and therapy response of the disorder (Weizman et al., 1994; Sluzewska et al., 1995; Frommberger et al., 1997; Maes et al., 1997; Licinio and Wong, 1999; Lanquillon et al., 2000; Anisman and Merali, 2003).”
BackgroundZobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Cytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
Corticosteroid Receptor Function Is Decreased in Depressed Patients
Modell, S., Yassouridis, A., Huber, J., & Holsboer, F. (2008) · Neuroendocrinology · doi:10.1159/000127275 · Cited by 204
Research works printed but not linked: 30
- Bauer, 2003, Altered glucocorticoid immunoregulation in treatment resistant depression, Psychoneuroendocrinology, 28, 49, 10.1016/S0306-4530(02)00009-4 · DOI
- Baumgartner, 1996, Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines, J. Immunol., 157, 4087, 10.4049/jimmunol.157.9.4087 · doi:10.4049/jimmunol.157.9.4087
- Cupps, 1982, Corticosteroid-mediated immunoregulation in man, Immunol. Rev., 65, 133, 10.1111/j.1600-065X.1982.tb00431.x · DOI · Paper page
- Dantzer, 2001, Cytokine-induced sickness behavior: mechanisms and implications, Ann. N. Y. Acad. Sci., 933, 222, 10.1111/j.1749-6632.2001.tb05827.x · DOI · Paper page
- De Groote, 1993, Novel method for the measurement of cytokine production by a one-stage procedure, J. Immunol. Methods, 163, 259, 10.1016/0022-1759(93)90130-Y · DOI
- De Kloet, 1994, Cytokines and the brain corticosteroid receptor balance: relevance to pathophysiology of neuroendocrine-immune communication, Psychoneuroendocrinology, 19, 121, 10.1016/0306-4530(94)90002-7 · DOI
- DeRijk, 1997, Corticosteroid resistance and disease, Ann. Med., 29, 79, 10.3109/07853899708998746 · DOI · Paper page
- Dhabhar, 1999, Enhancing versus suppressive effects of stress hormones on skin immune function, Proc. Natl. Acad. Sci. U. S. A., 96, 1059, 10.1073/pnas.96.3.1059 · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Herbert, 1993, Depression and immunity: a meta-analytic review, Psychol. Bull., 113, 472, 10.1037/0033-2909.113.3.472 · DOI · Paper page
- Holsboer, 2000, The corticosteroid receptor hypothesis of depression (review), Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 · DOI · Paper page
- Ising, 2007, CRH-sub-1 receptor antagonists for the treatment of depression and anxiety, Exp. Clin. Psychopharmacol., 15, 519, 10.1037/1064-1297.15.6.519 · DOI · Paper page
- Kok, 1995, Immunoglobulin production in vitro in major depression: a pilot study on the modulating action of endogenous cortisol, Biol. Psychiatry, 38, 217, 10.1016/0006-3223(94)00297-G · doi:10.1016/0006-3223(94)00297-g
- Leonard, 2000, Stress, depression and the activation of the immune system (review), World J. Biol. Psychiatry, 1, 17, 10.3109/15622970009150562 · DOI · Paper page
- Lim-Tio, 1997, Determinants of specificity of transactivation by the mineralocorticoid or glucocorticoid receptor, Endocrinology, 138, 2537, 10.1210/en.138.6.2537 · DOI
- Maes, 1995, Evidence for an immune response in major depression: a review and hypothesis, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 19, 11, 10.1016/0278-5846(94)00101-M · DOI · Paper page
- Maes, 1993, Relationships between interleukin-6 activity, acute phase proteins and function of the hypothalamic-pituitary-adrenal axis in severe depression, Psychiatry Res., 49, 11, 10.1016/0165-1781(93)90027-E · DOI · Paper page
- Maes, 1997, Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression, Cytokine, 9, 853, 10.1006/cyto.1997.0238 · DOI · Paper page
- Mikova, 2001, Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis, Eur. Neuropsychopharmacol., 11, 203, 10.1016/S0924-977X(01)00081-5 · DOI · Paper page
- Miller, 2005, Clinical depression and regulation of the inflammatory response during acute stress, Psychosom. Med., 67, 679, 10.1097/01.psy.0000174172.82428.ce · DOI · Paper page
- Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
- Moynagh, 2003, Toll-like receptor signaling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids, J. Endocrinol., 179, 139, 10.1677/joe.0.1790139 · DOI
- Rakasz, 1993, Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokins Interleukin (IL)-1β, IL-6 and Tumour Necrosis Factor (TNF)-α, Scand. J. Immunol., 37, 684, 10.1111/j.1365-3083.1993.tb01684.x · DOI · Paper page
- Renz, 1992, Sensitization of rat alveolar macrophages to enhanced TNF-α release by in vivo treatment with dexamethasone, Cell. Immunol., 144, 249, 10.1016/0008-8749(92)90242-H · DOI
- Ribeiro, 1993, The DST as a predictor of outcome in depression: a meta-analysis, Am. J. Psychiatry, 150, 1618, 10.1176/ajp.150.11.1618 · DOI · Paper page
- Sapolsky, 2000, How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions, Endocr. Rev., 21, 55, 10.1210/er.21.1.55 · DOI · Paper page
- Sluzewska, 1995, Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine, Ann. N.Y. Acad. Sci., 762, 474, 10.1111/j.1749-6632.1995.tb32372.x · DOI · Paper page
- Tichomirowa, 2005, Endocrine disturbances in depression, J. Endocrinol. Investig., 28, 89, 10.1007/BF03345535 · DOI
- Wodarz, 1991, Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression, J. Affect. Disord., 22, 241, 10.1016/0165-0327(91)90070-9 · DOI
- Yu, 2008, Neuronal actions of glucocorticoids: focus on depression, J. Steroid Biochem. Mol. Biol., 108, 300, 10.1016/j.jsbmb.2007.09.014 · DOI
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Cytokines as biomarkers in depressive disorder: current standing and prospects
Lichtblau, N., Schmidt, F. M., Schumann, R., Kirkby, K. C., & Himmerich, H. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.813442 · Cited by 155
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
“Indeed, pro-inflammatory cytokines have been found to be elevated in the blood of depressed patients [4], and following in vitro stimulation, lymphocytes of depressed patients showed significantly stronger activation of production of IL-1β, IL-6 and TNF-α compared to normal controls [5].”
BackgroundInfluentialPerrin, A. J., Horowitz, M. A., Roelofs, J., Zunszain, P. A., & Pariante, C. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00423 · Cited by 112
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Metadata
- Authors
- Heiser, P., Lanquillon, S., Krieg, J.-C., & Vedder, H.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 18
- Issue
- 12
- Pages
- 860-870
- ISSN
- 0924-977X
- Cited by
- 11
- References
- 15
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasone. https://app.cochat.ai/papers/10.1016/j.euroneuro.2008.07.003
- The paper
- Heiser, P., Lanquillon, S., Krieg, J.-C., & Vedder, H. (2008). Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasone. European Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2008.07.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.